SCHEMBL515388

SCHEMBL515388

C=CCCCCC(=O)CC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
ABCC4 O15439 1/20 0.56
ALDH1A1 P00352 4/20 0.53
LMNA P02545 3/20 0.53
TSHR P16473 4/20 0.46
FAAH O00519 3/20 0.41
TDP1 Q9NUW8 1/20 0.39
USP2 O75604 2/20 0.39
RECQL P46063 2/20 0.39
CYP3A4 P08684 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GMNN O75496 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
APEX1 P27695 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9305406 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL514190 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL9304385 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL515245 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL3120677 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL8408162 0.98 MAPT (0.59) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL11859532 0.96 MAPT (0.57) MAPTABCC4ALDH1A1LMNATSHR
Methylamine SCHEMBL27712930 0.94 MAPT (0.55) MAPTABCC4ALDH1A1LMNATSHR
SCHEMBL514517 0.93
SCHEMBL23209767 0.90 ALDH1A1 (0.53) MAPTABCC4ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111278821-B Spiro compounds as farnesol X receptor modulators 百时美施贵宝公司 2023-10-03 CN disclosed
CN-111278821-A Spiro compounds as farnesoid X receptor modulators 百时美施贵宝公司 2020-06-12 CN disclosed
CN-102369173-B Method for producing high-purity terminal olefin compound KURARAY CO 2014-09-10 CN disclosed
EP-2415740-B1 METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND KURARAY CO (JP) 2013-12-25 EP disclosed
US-8609886-B2 Method for producing high purity terminal olefin compound KURARAY CO., LTD. (JP) 2013-12-17 US disclosed
CN-102369173-A Method for producing high-purity terminal olefin compound KURARAY CO 2012-03-07 CN disclosed
EP-2415740-A1 METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND Kuraray Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND KURARAY CO., LTD. (JP) 2012-02-02 US disclosed
US-7714087-B2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2010-05-11 US disclosed
EP-1734061-B1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS INC (JP) 2010-04-07 EP disclosed
US-20090137757-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof IMUTA JUNICHI 2009-05-28 US disclosed
US-7393907-B2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2008-07-01 US disclosed
EP-1734061-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS, INC. (JP) 2006-12-20 EP disclosed
US-20040122192-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. 2004-06-24 US disclosed
US-20020156207-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2002-10-24 US disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND ADH1A, ADH1C, OSBP MAPT 1768/4885ABCC4 4712/4885ALDH1A1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.